• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性浆液性黄斑脱离和视觉障碍并发连续多例有症状的玻璃体黄斑粘连伴黄斑裂孔经奥克纤溶酶治疗的情况

Chronic Serous Macular Detachments and Visual Disturbance Complicating Consecutive Cases of Symptomatic Vitreomacular Adhesion With Macular Hole Treated With Ocriplasmin.

作者信息

Luttrull Jeffrey K

出版信息

Ophthalmic Surg Lasers Imaging Retina. 2015 Oct;46(9):976-8. doi: 10.3928/23258160-20151008-13.

DOI:10.3928/23258160-20151008-13
PMID:26469240
Abstract

Two consecutive cases of symptomatic vitreomacular adhesion with macular hole were treated with intravitreal ocriplasmin. Both were complicated by long-term visual symptoms and chronic serous foveal detachments lasting 17 months post-treatment. These findings suggest direct and long-lasting effects of ocriplasmin on the retinal pigment epithelium and/or outer retina. Patients treated with ocriplasmin should be cautioned that the side effects of even successful drug treatment may prolong visual recovery compared to vitrectomy.

摘要

两例连续的伴有黄斑裂孔的症状性玻璃体黄斑粘连患者接受了玻璃体内注射奥克纤溶酶治疗。两者均伴有长期视觉症状和治疗后持续17个月的慢性浆液性黄斑脱离。这些发现提示奥克纤溶酶对视网膜色素上皮和/或外层视网膜有直接和持久的作用。接受奥克纤溶酶治疗的患者应被告知,与玻璃体切除术相比,即使药物治疗成功,其副作用也可能延长视力恢复时间。

相似文献

1
Chronic Serous Macular Detachments and Visual Disturbance Complicating Consecutive Cases of Symptomatic Vitreomacular Adhesion With Macular Hole Treated With Ocriplasmin.慢性浆液性黄斑脱离和视觉障碍并发连续多例有症状的玻璃体黄斑粘连伴黄斑裂孔经奥克纤溶酶治疗的情况
Ophthalmic Surg Lasers Imaging Retina. 2015 Oct;46(9):976-8. doi: 10.3928/23258160-20151008-13.
2
Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.在使用奥克纤溶酶治疗症状性玻璃体黄斑粘连/玻璃体黄斑牵拉(包括与黄斑裂孔相关时)的MIVI-TRUST研究中,解剖学分辨率与功能预后之间的关联。
Retina. 2015 Jun;35(6):1151-7. doi: 10.1097/IAE.0000000000000508.
3
Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵拉和黄斑裂孔后,光谱域光学相干断层扫描(SD-OCT)显示的视网膜外层反射率变化
Retina. 2015 Jun;35(6):1144-50. doi: 10.1097/IAE.0000000000000544.
4
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.ocriplasmin 治疗症状性玻璃体黄斑牵引综合征的解剖和视觉结果。
Br J Ophthalmol. 2014 Mar;98(3):356-60. doi: 10.1136/bjophthalmol-2013-304219. Epub 2013 Dec 19.
5
Ocriplasmin-Induced Macular Hole Closure in the Absence of Vitreomacular Adhesion Release.在未解除玻璃体黄斑粘连的情况下,玻璃体内注射奥克纤溶酶诱导黄斑裂孔闭合
Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):677-9. doi: 10.3928/23258160-20150610-14.
6
Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection.玻璃体内注射欧立珠单抗后急性全视网膜结构和功能异常。
JAMA Ophthalmol. 2014 Apr 1;132(4):484-6. doi: 10.1001/jamaophthalmol.2013.8142.
7
Does ocriplasmin affect the RPE-photoreceptor adhesion in macular holes?奥克纤溶酶是否会影响黄斑裂孔中视网膜色素上皮细胞与光感受器的黏附?
Br J Ophthalmol. 2015 May;99(5):635-8. doi: 10.1136/bjophthalmol-2014-305620. Epub 2014 Nov 17.
8
SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION: A Comprehensive Analysis of Premarketing and Postmarketing Experiences.用于有症状性玻璃体黄斑粘连的奥克裂纤酶的安全性概况:上市前和上市后经验的综合分析
Retina. 2015 Jun;35(6):1128-34. doi: 10.1097/IAE.0000000000000519.
9
Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵拉和黄斑裂孔的并发症:一项前瞻性光谱域光学相干断层扫描研究
Cutan Ocul Toxicol. 2016 Dec;35(4):263-9. doi: 10.3109/15569527.2015.1096941. Epub 2015 Nov 10.
10
Ocriplasmin: nonsurgical option for VMA and macular hole, but with potential barriers to practical use.奥克纤溶酶:玻璃体黄斑粘连和黄斑裂孔的非手术治疗选择,但在实际应用中存在潜在障碍。
Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):113-6; discussion p.113. doi: 10.3928/23258160-20130313-02.

引用本文的文献

1
Ocriplasmin: who is the best candidate?奥克纤溶酶:最佳适用人群是谁?
Clin Ophthalmol. 2016 Mar 17;10:485-95. doi: 10.2147/OPTH.S97947. eCollection 2016.